Dechao Yu

4.0k total citations
57 papers, 2.7k citations indexed

About

Dechao Yu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Dechao Yu has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Genetics and 18 papers in Oncology. Recurrent topics in Dechao Yu's work include Virus-based gene therapy research (26 papers), Cancer Research and Treatments (18 papers) and CAR-T cell therapy research (13 papers). Dechao Yu is often cited by papers focused on Virus-based gene therapy research (26 papers), Cancer Research and Treatments (18 papers) and CAR-T cell therapy research (13 papers). Dechao Yu collaborates with scholars based in United States, China and United Kingdom. Dechao Yu's co-authors include Daniel Henderson, Gordon T. Sakamoto, Yu Chen, Nagarajan Ramesh, Peter K. Working, Jeanette Dilley, Shanthi Ganesh, P. Seshidhar Reddy, Michael A. Carducci and Hongxin Deng and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Dechao Yu

57 papers receiving 2.6k citations

Peers

Dechao Yu
Richard Harrop United Kingdom
Kevin Gorski United States
Peter Yaciuk United States
Martin J. Allday United Kingdom
Patrick Saulnier France
Katherine Ruffner United States
Ellen I. H. van der Voort Netherlands
Britta Randlev United States
Birthe Sauter United States
Xiaopei Huang United States
Richard Harrop United Kingdom
Dechao Yu
Citations per year, relative to Dechao Yu Dechao Yu (= 1×) peers Richard Harrop

Countries citing papers authored by Dechao Yu

Since Specialization
Citations

This map shows the geographic impact of Dechao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dechao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dechao Yu more than expected).

Fields of papers citing papers by Dechao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dechao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dechao Yu. The network helps show where Dechao Yu may publish in the future.

Co-authorship network of co-authors of Dechao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Dechao Yu. A scholar is included among the top collaborators of Dechao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dechao Yu. Dechao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauhan, Deepak S., Kun Shao, Roopa Hebbandi Nanjundappa, et al.. (2025). Comparative Analysis of Clinical Outcomes and Financial Aspects of Phototherapies and Immunotherapy for Cancer. Advanced Science. 12(30). e17657–e17657. 2 indexed citations
2.
Dai, Lei, Yi Liu, Lin Cheng, et al.. (2019). SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells. Mucosal Immunology. 12(5). 1130–1140. 19 indexed citations
3.
Yin, Xiangke, Xianchai Lin, Xiangrong Ren, et al.. (2019). Novel multi-targeted inhibitors suppress ocular neovascularization by regulating unique gene sets. Pharmacological Research. 146. 104277–104277. 5 indexed citations
4.
Tian, Hongwei, Gang Shi, Qin Wang, et al.. (2016). A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity. Signal Transduction and Targeted Therapy. 1(1). 16025–16025. 43 indexed citations
5.
Deng, Jie, Qingyuan Jiang, Yuan Wang, et al.. (2016). Rapid generation of functional hepatocyte-like cells from human adipose-derived stem cells. Stem Cell Research & Therapy. 7(1). 105–105. 21 indexed citations
6.
Xu, Fen, Jun‐Li Liu, Jie Deng, et al.. (2015). Rapid and high-efficiency generation of mature functional hepatocyte-like cells from adipose-derived stem cells by a three-step protocol. Stem Cell Research & Therapy. 6(1). 193–193. 18 indexed citations
7.
Liu, Yu, Junfeng Zhang, Lei Dai, et al.. (2015). Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis. International Immunopharmacology. 28(1). 731–743. 32 indexed citations
8.
Du, Ting, Gang Shi, Hongwei Tian, et al.. (2014). Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers. Cancer Gene Therapy. 21(8). 340–348. 43 indexed citations
9.
Yu, Dechao, Jung‐Sun Lee, Ji Young Yoo, et al.. (2012). Soluble Vascular Endothelial Growth Factor Decoy Receptor FP3 Exerts Potent Antiangiogenic Effects. Molecular Therapy. 20(5). 938–947. 31 indexed citations
10.
Chang, Jianhua, Xianghua Wu, Ye Guo, et al.. (2009). A phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: Armed oncolytic adenovirus for the treatment of head and neck cancers. Cancer Biology & Therapy. 8(8). 676–682. 66 indexed citations
11.
Wang, Hui, Jing Shi, Qin Wang, et al.. (2009). Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE. Cancer Immunology Immunotherapy. 59(2). 239–246. 5 indexed citations
12.
13.
Farson, Deborah, et al.. (2006). Development of Novel E1-Complementary Cells for Adenoviral Production Free of Replication-Competent Adenovirus. Molecular Therapy. 14(2). 305–311. 8 indexed citations
14.
Small, Eric J., Michael A. Carducci, James M. Burke, et al.. (2006). A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer. Molecular Therapy. 14(1). 107–117. 185 indexed citations
15.
Ramesh, Nagarajan, et al.. (2005). CG0070, a conditionally replicating GM-CSF armed oncolytic adenovirus for the treatment of bladder cancer. Cancer Research. 65. 1185–1185. 3 indexed citations
16.
Borovjagin, Anton V., et al.. (2005). Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. Cancer Gene Therapy. 12(5). 475–486. 38 indexed citations
17.
Ramesh, Nagarajan, et al.. (2004). Identification of Pretreatment Agents to Enhance Adenovirus Infection of Bladder Epithelium. Molecular Therapy. 10(4). 697–705. 34 indexed citations
18.
Yu, Dechao, Alice L. Wang, Christopher Botka, & Ching C. Wang. (1998). Protein synthesis in Giardia lamblia may involve interaction between a downstream box (DB) in mRNA and an anti-DB in the 16S-like ribosomal RNA. Molecular and Biochemical Parasitology. 96(1-2). 151–165. 26 indexed citations
19.
Yu, Dechao, et al.. (1996). Stable coexpression of a drug-resistance gene and a heterologous gene in an ancient parasitic protozoan Giardia lamblia. Molecular and Biochemical Parasitology. 83(1). 81–91. 30 indexed citations
20.
Yu, Dechao, et al.. (1995). Virus-Mediated Expression of Firefly Luciferase in the Parasitic Protozoan Giardia lamblia. Molecular and Cellular Biology. 15(9). 4867–4872. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Harrop Breakdown of academic impact, for papers by Kevin Gorski Breakdown of academic impact, for papers by Peter Yaciuk Breakdown of academic impact, for papers by Martin J. Allday Breakdown of academic impact, for papers by Patrick Saulnier Breakdown of academic impact, for papers by Katherine Ruffner Breakdown of academic impact, for papers by Ellen I. H. van der Voort Breakdown of academic impact, for papers by Britta Randlev Breakdown of academic impact, for papers by Birthe Sauter Breakdown of academic impact, for papers by Xiaopei Huang
Rankless by CCL
2026